• Home
  • Contact

India’s first COVID-19 vaccine ‘COVAXIN’ gets DCGI nod for human trials

Biotech Today — June 29, 2020 in News 3 Likes 57 Views Share TwitterTweet on Twitter FacebookShare on Facebook Google+Google+ PinterestPinterest

COVAXIN, India’s first vaccine candidate against the COVID-19 gets nod from Drugs Controller General of India (DCGI) for human trials.

The post India’s first COVID-19 vaccine ‘COVAXIN’ gets DCGI nod for human trials appeared first on BioTech Times.

Source

COVAXIN Covid-19 Vaccine DCGI Drugs Drugs Controller General of India human clinical trials Indian COVID-19 vaccine News

About the Author: Biotech Today

You might like

The Promises of CRISPR Genome Editing in Biomedicine

1 day ago 0 Likes 3

How is Bioprocessing 4.0 Revolutionizing Biomanufacturing?

2 days ago 0 Likes 2

How Are European Biotechs Tackling the Cardiovascular Disease Problem?

3 days ago 0 Likes 8

Infographic: The Biopharmaceutical Factory of the Future

7 days ago 1 Likes 10

Legal Fights Accompany Big Fundraises in Liquid Biopsy Scene

7 days ago 2 Likes 11

Exosome Therapy: Borrowing from Nature’s Toolbox

1 week ago 1 Likes 11

Recent Posts

  • The Promises of CRISPR Genome Editing in Biomedicine
  • How is Bioprocessing 4.0 Revolutionizing Biomanufacturing?
  • How Are European Biotechs Tackling the Cardiovascular Disease Problem?
  • Infographic: The Biopharmaceutical Factory of the Future
  • Legal Fights Accompany Big Fundraises in Liquid Biopsy Scene
  • Exosome Therapy: Borrowing from Nature’s Toolbox
  • How Automation Can Augment Drug Discovery Research  
  • Cannabinoids in Focus after GW Pharmaceuticals Snapped up for €6B
  • To Reach Mars, We Need Biotechnology
  • Can Better Disease Modeling Help Fight Neurological Diseases?
© 2020 biotechTODAY - Designed by Legendary Group